Location History:
- Richmond, CA (2022)
- Vancouver, CA (2022 - 2024)
Company Filing History:
6 out of 23 
4 out of 932 
Years Active: 2022-2025
Title: Kuo-Shyan Lin: Innovator in Theranostic Compounds
Introduction
Kuo-Shyan Lin is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of theranostic compounds, which combine therapeutic and diagnostic capabilities. With a total of 6 patents, Lin's work is at the forefront of medical innovation.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Dual mode 18F-labelled theranostic compounds and uses thereof." This patent describes a compound or molecular complex that includes a metal chelator designed for chelation with either a radioactive or non-radioactive isotope, along with a trifluoroborate-containing moiety. Additionally, it may include a cell-targeting domain. Another notable patent is for "Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders." This patent presents peptidic compounds with specific formulas that can serve as imaging or therapeutic agents.
Career Highlights
Kuo-Shyan Lin has worked with reputable organizations such as the Provincial Health Services Authority and the University of British Columbia. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Lin has collaborated with esteemed colleagues, including François Bénard and Chengcheng Zhang. These partnerships have further enhanced the impact of his research in the field.
Conclusion
Kuo-Shyan Lin's contributions to theranostic compounds exemplify the intersection of innovation and healthcare. His patents and collaborations continue to pave the way for advancements in medical diagnostics and treatment.